Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 6 47-6, 2003, Pages

  Huang, Zhiping ^a   Inazu, Akihiro ^a   Kawashiri, Masa aki ^a   Nohara, Atsushi ^a   Higashikata, Toshinori ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

High density lipoprotein; Reverse cholesterol transport; Scavenger receptor class B type I

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL OLEATE; HIGH DENSITY LIPOPROTEIN; IODINE 125; SCAVENGER;

ARTICLE; CATABOLISM; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0038324026     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00453.2002     Document Type: Article

References (53)

1. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520, 1996.
2. Agellon LB, Zhang P, Jiang XC, Mendelsohn L, and Tall AR. The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter. J Biol Chem 267: 22336-22339, 1992.
3. Auwerx JH, Chait A, Wolfbauer G, and Deeb SS. Involvement of second messengers in regulation of the low-density lipoprotein receptor gene. Mol Cell Biol 9: 2298-22302, 1989.
4. Benoist F, Lau P, McDonnell M, Doelle H, Milne R, and McPherson R. Cholesteryl ester transfer protein mediates selective uptake of high density lipoprotein cholesteryl esters by human adipose tissue. J Biol Chem 272: 23572-23577, 1997.
5. Bisgaier CL, Siebenkas MV, Brown ML, Inazu A, Koizumi J, Mabuchi H, and Tall AR. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin. J Lipid Res 32: 21-33, 1991.
6. Block LH, Matthys H, Emmons LR, Perruchoud A, Erne P, and Roth M. Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc Natl Acad Sci USA 88: 9041-9045, 1991.
7. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, and Tall AR. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342: 448-451, 1989.
8. Brown MS and Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell 89: 331-340, 1997.
9. Collet X, Tall AR, Serajuddin H, Guendouzi K, Royer L, Oliveira H, Barbaras R, Jiang XC, and Francone OL. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res 40: 1185-1193, 1999.
10. Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, Fielding C, and Lawn R. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327: 632-634, 1987.
11. Fluiter K, van der Westhuijzen DR, and van Berkel TJ. In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells. J Biol Chem 273: 8434-8438, 1998.
12. Francis GA, Ko KW, Hara H, and Yokoyama S. Regulation of the uptake of high-density lipoprotein-originated cholesteryl ester by HepG2 cells: role of low-density lipoprotein and plasma lipid transfer protein. Biochim Biophys Acta 1084: 159-166, 1991.
13. Goldstein JL, Basu SK, and Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98: 241-260, 1983.
14. Harkes L and van Berkel TJ. Cellular localization of the receptor-dependent and receptor-independent uptake of human LDL in the liver of normal and 17 alpha-ethinyl estradiol-treated rats. FEBS Lett 154: 75-80, 1983.
15. Hashimoto S, Morton RE, and Zilversmit DB. Facilitated transfer of cholesteryl ester between rough and smooth microsomal membranes by plasma lipid transfer protein. Biochem Biophys Res Commun 120: 586-592, 1984.
16. Hatch FT. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1-68, 1968.
17. Havel RJ, Eder HA, and Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353, 1955.
18. Heider JG and Boyett RL. The picomole determination of free and total cholesterol in cells in culture. J Lipid Res 19: 514-518, 1978.
19. Ikewaki K, Nishiwaki M, Sakamoto T, Ishikawa T, Fair-well T, Zech LA, Nagano M, Nakamura H, Brewer HB Jr, and Rader DJ. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest 96: 1573-1581, 1995.
20. Ikewaki K, Rader DJ, Sakamoto T, Nishiwaki M, Wakimoto N, Schaefer JR, Ishikawa T, Fairwell T, Zech LA, Nakamura H, Nagano M, and Brewer BH. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest 92: 1650-1658, 1993.
21. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, and Tall AR. Increased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutation. N Engl J Med 323: 1234-1238, 1990.
22. Inazu A, Koizumi J, and Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 11: 389-396, 2000.
23. Inazu A, Quinet EM, Wang S, Brown ML, Stevenson S, Barr ML, Moulin P, and Tall AR. Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein. Biochemistry 31: 2352-2358, 1992.
24. Izem L and Morton RE. Cholesteryl ester transfer protein biosynthesis and cellular cholesterol homeostasis are tightly interconnected. J Biol Chem 276: 26534-26541, 2001.
25. Johnson WJ, Mahlberg FH, Rothblat GH, and Phillips MC. Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta 1085: 273-298, 1991.
26. Kiyohara T, Kiriyama R, Zamma S, Inazu A, Koizumi J, Mabuchi H, and Chichibu K. Enzyme immunoassay for cholesteryl ester transfer protein in human serum. Clin Chim Acta 271: 109-118, 1998.
27. Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, and Schmitz G. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 97: 817-822, 2000.
28. Koizumi J, Mabuchi H, Yoshimura A, Michishita I, Takeda M, Itoh H, Sakai Y, Sakai T, Ueda K, and Takeda R. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 58: 175-186, 1985.
29. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, and Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387: 414-417, 1997.
30. Liao W and Chan L. Tunicamycin induces ubiquitination and degradation of apolipoprotein B in HepG2 cells. Biochem J 353: 493-501, 2001.
31. Liu J, Zhang YL, Spence MJ, Vestal RE, Wallace PM, and Grass DS. Liver LDL receptor mRNA expression is decreased in human ApoB/CETP double transgenic mice and is regulated by diet as well as the cytokine oncostatin M. Arterioscler Thromb Vasc Biol 17: 2948-2954, 1997.
32. Lopez D and McLean MP. Sterol regulatory element-binding protein-1a binds to cis elements in the promoter of the rat high density lipoprotein receptor SR-BI gene. Endocrinology 140: 5669-5681, 1999.
33. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
34. Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Horiuchi S, and Matsuda I. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J Lipid Res 36: 696-704, 1995.
35. Okamoto H, Yonemori F, Wakitani K, Minowa T, Maeda K, and Shinkai H. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature 406: 203-207, 2000.
36. Pittman RC, Class CK, Atkinson GD, and Small DM. Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters. J Biol Chem 262: 2435-2442, 1987.
37. Raungaard B, Heath F, Brorholt-Petersen JU, Jensen HK, and Faergemaan O. Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia. Clin Chem 44: 966-972, 1998.
38. Richard BM, Pfeuffer MA, and Pittman RC. Transport of HDL cholesterol esters to the liver is not diminished by probucol treatment in rats. Arterioscler Thromb Vasc Biol 12: 862-869, 1992.
39. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, and Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 94: 12610-12615, 1997.
40. Rumsey SC, Galeano NF, Lipschitz B, and Deckelbaum RJ. Oleate and other long chain fatty acids stimulate low density lipoprotein receptor activity by enhancing acyl coenzyme A:cholesterol acyltransferase activity and altering intracellular regulatory cholesterol pools in cultured cells. J Biol Chem 270: 10008-10016, 1995.
41. Sawada S, Sugano M, Makino N, Okamoto H, and Tsuchida K. Secretion of prebeta HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells. Atherosclerosis 146: 291-298, 1999.
42. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, and Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73: 284-289, 1989.
43. Sperker B, Mark M, and Budzinski RM. The expression of human plasma cholesteryl-ester-transfer protein in HepG2 cells is induced by sodium butyrate. Quantification of low mRNA levels by polymerase chain reaction. Eur J Biochem 218: 945-950, 1993.
44. Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, Kamada M, and Mizushima A. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem 273: 5033-5036, 1998.
45. Sun Y, Wang N, and Tall AR. Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools. J Lipid Res 40: 1799-1805, 1999.
46. Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 86: 379-384, 1990.
47. Ueda Y, Royer L, Gong E, Zhang J, Cooper PN, Francone O, and Rubin EM. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 274: 7165-7171, 1999.
48. Wagner RW. The state of the art in antisense research. Nat Med 11: 1116-1118, 1995.
49. Wang N, Silver D, Costet P, and Tall AR. Specific binding of apoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 275: 33053-33058, 2000.
50. Wang N, Weng W, Breslow JL, and Tall AR. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J Biol Chem 271: 21001-21004, 1996.
51. Webb NR, de Villiers WJ, Connell PM, de Beer FC, and van der Westhuyzen DR. Alternative forms of the scavenger receptor BI (SR-BI). J Lipid Res 38: 1490-1495, 1997.
52. Widom RL, Rhee M, and Karathanasis SK. Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid. Mol Cell Biol 12: 3380-3389, 1992.
53. Yang TP, Agellon LB, Walsh A, Breslow JL, and Tall AR. Alternative splicing of the human cholesteryl ester transfer protein gene in transgenic mice. Exon exclusion modulates gene expression in response to dietary or developmental change. J Biol Chem 271: 12603-12609, 1996.